LRRC9: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

Target Name: LRRC9

NCBI ID: G341883

LRRC9

Other Name(s): Leucine rich repeat containing 9, transcript variant 2 | leucine rich repeat containing 9 | LRRC9 variant 2

LRRC9: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

The protein encoded by the gene LRRC9 (Leucine rich repeat containing 9) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. LRRC9 is a member of the leucine rich repeat (LRR) family, which are characterized by the repeated sequence of the amino acid leucine in a protein. LRRs are known to play a critical role in the regulation of various cellular processes, including cell signaling, DNA replication, and protein stability.

The LRRC9 gene was first identified in the genomic sequence database as having potential for being a gene that encodes a protein with functions in various cellular processes. Subsequent studies have demonstrated that LRRC9 is indeed a non-coding RNA molecule that contains a repeated sequence of leucine residues. LRRC9 has also been shown to have a unique expression pattern in various tissues and organisms, which may be related to its potential function as a drug target or biomarker.

Potential Drug Target

The potential drug target for LRRC9 is its role in cell signaling. LRRC9 has been shown to play a critical role in the regulation of various cellular processes, including cell signaling, cell growth, and cell division. LRRC9 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

LRRC9 has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, cell differentiation, and cell survival. LRRC9 has been shown to play a critical role in the regulation of TGF-β signaling by binding to the protein SMAD2, which is a key component of the TGF-β pathway.

In addition to its role in cell signaling, LRRC9 has also been shown to be involved in the regulation of DNA replication and protein stability. LRRC9 has been shown to play a critical role in the regulation of DNA replication, as well as the regulation of protein stability in various cellular processes.

Potential Biomarker

The potential use of LRRC9 as a biomarker is based on its unique expression pattern in various tissues and organisms. LRRC9 has been shown to have a highly expressed expression pattern in various tissues, including the brain, heart, and liver. This may suggest that LRRC9 is involved in the regulation of important cellular processes in these tissues, which could make it an attractive biomarker for the development of new diagnostic tests or therapies.

LRRC9 has also been shown to have a unique expression pattern in various organisms, which may be related to its function as a drug target. The expression patterns of LRRC9 have been shown to be different between mammalian cells and Escherichia coli cells, which may suggest that LRRC9 has a unique function in these organisms.

Conclusion

In conclusion, LRRC9 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. LRRC9 has been shown to play a critical role in the regulation of various cellular processes, including cell signaling, DNA replication, and protein stability. Its unique expression pattern in various tissues and organisms may make it an attractive biomarker for the development of new diagnostic tests or therapies. Further research is needed to fully understand the function of LRRC9 and its potential as a drug target and biomarker.

Protein Name: Leucine Rich Repeat Containing 9

The "LRRC9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets